✦ LIBER ✦

Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a: A study by the Italian trials in Medical Oncology Group

✍ Scribed by Emilio Bajetta; Nicoletta Zilembo; Maria Di Bartolomeo; Angelo Di Leo; Silvana Pilotti; Anna Maria Bochicchio; Rita Castellani; Roberto Buzzoni; Luigi Celio; Luigi Dogliotti; Gabriella Pinotti; Enrico Aitini; Roberto Labianca; Adriano Fornasiero; Pietro Riva; Giuseppe Schieppati; Patrizia Nelli; Luigi Mariani

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 636 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19931115)72:10<3099::aid-cncr2820721035>3.0.co;2-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical efficacy of octreotide in the t

Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors: A study by the Italian Trials in Medical Oncology group

✍ Maria Di Bartolomeo; Emilio Bajetta; Roberto Buzzoni; Luigi Mariani; Carlo Carna 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

## Background: The unsatisfactory control of neuroendocrine tumor growth with chemotherapy and/or interferon (ifn-2a) stimulated us to investigate the role of the somatostatin analogue octreotide (sms 201.995), which is reported to be highly effective in controlling carcinoid syndrome symptoms. oct

5-Fluorouracil and levofolinic acid with

5-Fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma : A randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group

✍ Giuseppe Colucci; Evaristo Maiello; Vittorio Gebbia; Francesco Giuliani; Giusepp 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Background: The objectives of the current study were: 1) to verify whether the addition of modulating low doses of interferon-2b (ifn) to 5-fluorouracil (5-fu) and levofolinic acid (1-fa) could improve clinical results in patients with advanced colorectal carcinoma; and 2) to evaluate the role o